A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction
- PMID: 20736446
- DOI: 10.1161/CIRCINTERVENTIONS.110.957902
A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction
Abstract
Background: Experimental studies have shown that induction of hypothermia before reperfusion of acute coronary occlusion reduces infarct size. Previous clinical studies, however, have not been able to show this effect, which is believed to be mainly because therapeutic temperature was not reached before reperfusion in the majority of the patients. We aimed to evaluate the safety and feasibility of rapidly induced hypothermia by infusion of cold saline and endovascular cooling catheter before reperfusion in patients with acute myocardial infarction.
Methods and results: Twenty patients with acute myocardial infarction scheduled to undergo primary percutaneous coronary intervention were enrolled in this prospective, randomized study. After 4 ± 2 days, myocardium at risk and infarct size were assessed by cardiac magnetic resonance using T2-weighted imaging and late gadolinium enhancement imaging, respectively. A core body temperature of <35°C (34.7 ± 0.3°C) was achieved before reperfusion without significant delay in door-to-balloon time (43 ± 7 minutes versus 40 ± 6 minutes, hypothermia versus control, P=0.12). Despite similar duration of ischemia (174 ± 51 minutes versus 174 ± 62 minutes, hypothermia versus control, P=1.00), infarct size normalized to myocardium at risk was reduced by 38% in the hypothermia group compared with the control group (29.8 ± 12.6% versus 48.0 ± 21.6%, P=0.041). This was supported by a significant decrease in both peak and cumulative release of Troponin T in the hypothermia group (P=0.01 and P=0.03, respectively).
Conclusions: The protocol demonstrates the ability to reach a core body temperature of <35°C before reperfusion in all patients without delaying primary percutaneous coronary intervention and that combination hypothermia as an adjunct therapy in acute myocardial infarction may reduce infarct size at 3 days as measured by MRI.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00417638.
Comment in
-
Does cool reperfusion limit myocardial infarction injury?Circ Cardiovasc Interv. 2010 Oct;3(5):397-9. doi: 10.1161/CIRCINTERVENTIONS.110.958546. Circ Cardiovasc Interv. 2010. PMID: 20959597 No abstract available.
Similar articles
-
Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction.J Am Coll Cardiol. 2014 May 13;63(18):1857-65. doi: 10.1016/j.jacc.2013.12.027. Epub 2014 Feb 5. J Am Coll Cardiol. 2014. PMID: 24509284 Clinical Trial.
-
Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials.Ther Hypothermia Temp Manag. 2015 Jun;5(2):77-84. doi: 10.1089/ther.2015.0009. Epub 2015 May 18. Ther Hypothermia Temp Manag. 2015. PMID: 25985169
-
Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment- elevation myocardial infarction.Circ Cardiovasc Interv. 2015 Mar;8(3):e001965. doi: 10.1161/CIRCINTERVENTIONS.114.001965. Epub 2015 Feb 19. Circ Cardiovasc Interv. 2015. PMID: 25699687 Clinical Trial.
-
Therapeutic Hypothermia in STEMI.Cardiovasc Revasc Med. 2021 Aug;29:77-84. doi: 10.1016/j.carrev.2020.08.004. Epub 2020 Aug 7. Cardiovasc Revasc Med. 2021. PMID: 32807668 Review.
-
Intracoronary Hypothermia Before Reperfusion to Reduce Reperfusion Injury in Acute Myocardial Infarction: A Novel Hypothesis and Technique.Ther Hypothermia Temp Manag. 2017 Dec;7(4):199-205. doi: 10.1089/ther.2017.0006. Epub 2017 May 18. Ther Hypothermia Temp Manag. 2017. PMID: 28520548 Review.
Cited by
-
Mild therapeutic hypothermic protection activates the PI3K/AKT signaling pathway to inhibit TRPM7 and suppress ferroptosis induced by myocardial ischemia‑reperfusion injury.Mol Med Rep. 2024 Dec;30(6):220. doi: 10.3892/mmr.2024.13345. Epub 2024 Oct 4. Mol Med Rep. 2024. PMID: 39364741 Free PMC article.
-
Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke.Brain Circ. 2022 Jun 30;8(2):69-75. doi: 10.4103/bc.bc_27_22. eCollection 2022 Apr-Jun. Brain Circ. 2022. PMID: 35909706 Free PMC article. Review.
-
Cardioprotection by very mild hypothermia in mice.Cardiovasc Diagn Ther. 2019 Feb;9(1):64-67. doi: 10.21037/cdt.2018.08.07. Cardiovasc Diagn Ther. 2019. PMID: 30881880 Free PMC article.
-
SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI.J Soc Cardiovasc Angiogr Interv. 2024 Oct 7;3(11):102294. doi: 10.1016/j.jscai.2024.102294. eCollection 2024 Nov. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39649824 Free PMC article.
-
ACS network-based implementation of therapeutic hypothermia for the treatment of comatose out-of-hospital cardiac arrest survivors improves clinical outcomes: the first European experience.Scand J Trauma Resusc Emerg Med. 2013 Mar 25;21:22. doi: 10.1186/1757-7241-21-22. Scand J Trauma Resusc Emerg Med. 2013. PMID: 23531402 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical